What’s the down time? St Emlyn’s
There is one question that is always asked when a patient who has experienced a cardiac arrest is brought to the ED. What’s the downtime? (Nearly) Every team leader in […]
What’s the down time? St Emlyn’s Read More
Alternate defibrillation strategies in refractory ventricular fibrillation
Review of an RCT comparing dual sequence defibrillation against antero-lateral and antero-posterior pad positions
Alternate defibrillation strategies in refractory ventricular fibrillation Read More
Podcast – September 2022 Monthly Round Up
Our latest podcast round from September 2022. Simon and Iain wander through all that’s been happening this month.
Podcast – September 2022 Monthly Round Up Read More
Top trauma papers for #EuSEM22
It’s fantastic to be here in Berlin at the 2022 EuSEM conference. All conferences have their own personalities and this is no exception. There is something special about the cosmopolitan
Top trauma papers for #EuSEM22 Read More
Podcast – August 2022 Monthly Round Up
The latest @stemlyns podcast with @docib and @EMManchester. COVID, Calcium, chat and balance. Please do listen, like and subscribe. #FOAMed
Podcast – August 2022 Monthly Round Up Read More
Decisions, oscillations and damping. St Emlyn’s
Have you ever found yourself in a bit of a dilemma in a resuscitation as whether to perform a procedure? If you’re like me then you’ll be familiar with the
Decisions, oscillations and damping. St Emlyn’s Read More
JC: Fentanyl as an adjunct in RSI. Does it affect haemodynamic stability? St Emlyn’s
I’ve recently been spending a bit more time in the pre-hospital environment and it’s been interesting to compare practice there as compared to the emergency department. One theme has been
JC: Fentanyl as an adjunct in RSI. Does it affect haemodynamic stability? St Emlyn’s Read More
JC: Head up, mechanical and impedance device assisted CPR – does it make a difference? St Emlyn’s
Research in cardiac arrest management has improved a lot in recent years. We are now seeing large randomised controlled trials looking at specific therapies in the management of these critically